300529 健帆生物
按盤價 
31.450 +1.460 (+4.868%)
31.450 +1.460 (+4.868%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 24.597 | 12.987 | 25.661 | 38.822 | 35.370 |
| 總資產報酬率 ROA (%) | 14.217 | 7.965 | 17.397 | 29.821 | 30.649 |
| 投入資產回報率 ROIC (%) | 16.032 | 8.871 | 19.297 | 33.561 | 30.706 | 邊際利潤分析 |
| 銷售毛利率 (%) | 81.312 | 80.025 | 82.335 | 84.972 | 85.239 |
| 營業利潤率 (%) | 44.832 | 28.289 | 41.320 | 52.998 | 54.048 |
| 息稅前利潤/營業總收入 (%) | 44.524 | 25.340 | 40.097 | 52.132 | 51.507 |
| 淨利潤/營業總收入 (%) | 35.926 | 22.146 | 35.359 | 44.697 | 44.751 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.705 | 96.293 | 92.583 | 95.405 | 96.232 |
| 價值變動淨收益/利潤總額(%) | 2.622 | 0.000 | 1.034 | 2.041 | 1.472 |
| 營業外收支淨額/利潤總額(%) | -3.116 | -4.376 | -1.244 | -0.761 | -2.171 | 償債能力分析 |
| 流動比率 (X) | 3.771 | 3.993 | 4.592 | 7.911 | 6.005 |
| 速動比率 (X) | 3.413 | 3.529 | 4.105 | 7.402 | 5.640 |
| 資產負債率 (%) | 41.120 | 43.123 | 33.713 | 29.655 | 11.909 |
| 帶息債務/全部投入資本 (%) | 30.624 | 32.355 | 23.883 | 18.524 | -- |
| 股東權益/帶息債務 (%) | 216.684 | 197.769 | 304.068 | 421.911 | -11,339.709 |
| 股東權益/負債合計 (%) | 143.018 | 131.670 | 195.735 | 235.469 | 732.728 |
| 利息保障倍數 (X) | 42.508 | -14.371 | -56.060 | -112.140 | -37.000 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 10.291 | 27.770 | 35.460 | 29.367 | 0.000 |
| 存貨周轉天數 (天) | 229.497 | 344.136 | 223.177 | 142.015 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/10/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
